Martha Brumfield, PhD
Special Advisor, Past President and CEO
Critical Path Institute

Victoria Chiou, MD
Vice President, Clinical Development
Tempus AI

Rachele Hendricks-Sturrup, DHSc, MSc, MA
Research Director, Real World Evidence
Duke-Robert J. Margolis Institute for Health Policy

Lisa LaVange, PhD
Professor Emerita and former Chair
Gillings School of Global Public Health
University of North Carolina at Chapel Hill

Wendy R. Sanhai, PhD, MBA
Specialist Leader
Deloitte Consulting
Associate Professor
Duke University

Christy L. Shaffer, PhD
General Partner, Hatteras Venture Partners
Managing Director, Hatteras Discovery

Ann Taylor, MD
Co-Chair, Forum on Drug Discovery, Development and Translation
National Academies of Science, Engineering, and Medicine

Jonathan Watanabe, PharmD, PhD
Jere E. Goyan Presidential Chair for the Advancement of Pharmacy
School of Pharmacy
University of California San Francisco

Alastair J.J. Wood, M.B., Ch.B, FRCP, FACP (Chair)
Professor of Medicine, Emeritus
Professor of Pharmacology, Emeritus
Vanderbilt University

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute
Simon Stertzer Professor of Medicine
Stanford University

Additional members may be added to the committee.